Erasca, Inc.
ERAS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761918
No open-market purchases or sales by Erasca, Inc. insiders were filed in the last 90 days; 256 institutions reported holding it in 13F filings for Q2 2026, worth $5.13B in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Erasca, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 109 | 4 | 119 | +14 |
| Shares | 71.3M | 2.35M | 69.2M | +323.3K (+0.5%) |
| Value | $140.4M | $4.64M | $147.5M | +$11.8M (+8.7%) |
4 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (28)
Institutions that held Erasca, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (14)
Institutions that held Erasca, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Cormorant Asset Management, LP | 10,813,246 | $21.3M |
| ArrowMark Colorado Holdings LLC | 233,400 | $459.8K |
| ExodusPoint Capital Management, LP | 120,892 | $238.0K |
| PDT Partners, LLC | 42,651 | $84.0K |
| Virtus ETF Advisers LLC | 36,494 | $71.9K |
| Allspring Global Investments Holdings, LLC | 15,319 | $30.2K |
| Private Capital Advisors, Inc. | 12,500 | $29.0K |
| AQR Capital Management LLC | 13,058 | $25.7K |
| Franklin Resources Inc | 12,324 | $24.3K |
| Creative Planning | 11,609 | $22.9K |
| Quantbot Technologies LP | 9,798 | $19.3K |
| Nisa Investment Advisors, LLC | 5,568 | $11.0K |
| Parallel Advisors, LLC | 922 | $1.82K |
| Advisor Group Holdings, Inc. | 500 | $985 |
Not filed for Q4 2023 yet (4)
Institutions that held Erasca, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| International Biotechnology Trust PLC | 1,926,000 | $3.79M |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $615.6K |
| Innovis Asset Management LLC | 91,800 | $180.8K |
| Virginia Retirement Systems Et Al | 24,700 | $48.7K |